Selective pulmonary vasodilation induced by aerosolized zaprinast

Anesthesiology

Volumn 88, Issue 2, 1998, Pages 410-416

  Ichinose, Fumito ^a   Adrie, Christophe ^b   Hurford, William E ^c   Bloch, Kenneth D ^c   Zapol, Warren M ^c  

^a TEIKYO UNIVERSITY   (Japan)

^b SAINT LOUIS HOSPITAL   (France)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Guanosine 3',5' cyclic monophosphate phosphodiesterase; Inhaled nitric oxide; Nitric oxide toxicity; Plasma guanosine 3',5' cyclic monophosphate levels; Pulmonary hypertension

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; NITRIC OXIDE; ZAPRINAST;

AEROSOL; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; LAMB; LUNG BLOOD VESSEL; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; LUNG; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PULMONARY CIRCULATION; PURINONES; SHEEP; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0031891223     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199802000-00020     Document Type: Article

References (29)

1. Ignarro L Biological actions and properties of endotheliumderived nitric oxide formed and released from artery and vein. Circ Res 1989; 651-21
2. Ignarro L Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol 1990; 30535-60
3. Ignarro LJ Signal transuction mechanisms involving nitric oxide. Biochem Pharm 1991; 41485-90
4. Johns R Endothelium-derived relaxing factor Basic review and clinical implications. J Cardiothorac Vase Anesth 1991; 569-79
5. Johns R EDRF/nitric oxide, the endogenous nitrovasodilator and a new cellular messenger [Editorial]. ANESTHESIOLOGY 1991; 75927-31
6. Moncada S, Palmer RMJ, Higgs EA Nitric oxide Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 4310942
7. Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther 1984; 228682-90
8. Lugnier C, Schoeffter P, Bee A, Strouthou E, Stockt J Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharm 1986; 351743-51
9. Martin W, Villani G, Jothianandan D, Furchgott R Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232708-16
10. McMahon TJ, Ignarro LJ, Kadowitz PJ Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonaryvascular bed. J Appl Physiol 1993; 741704-11
11. McMahon TJ, Kadowitz PJ Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat. Am J Physiol 1992; 263(5 Pt l)L575-84
12. Palmer R, Fertige A, Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327524-6
13. Tolins J, Palmer R, Moncada S, Raij L Role of endotheliumderived relaxing factor in regulation of renal homodynamic responses. Am J Physiol 1992; 258H655-62
14. Braner DA, Fineman JR, Chang R, Soifer SJ M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 1993; 264H252-8
15. Thusu KG, Morin FCr, Russell JA, Steinhorn RH The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. AmJ Respir Crit Care Med 1995; 1521605-10
16. Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. AmJ Physiol 1995; 269H473-9
17. Ichinose F, Adrie C, Hurford W, Zapol W Prolonged pulmonary vasodilator action of inhaled nitric oxide by .Zaprinast in awake lambs. J Appl Physiol 1995; 781288-95
18. Skimming JW, DeMarco VG, Kadowitz PJ, Cassin S Effects of zaprinast and dissolved nitric oxide on the pulmonary circulation of fetal sheep. Pediatr Res 1996; 39223-8
19. McMahon EG, Palomo MA, Mehta P, Olins GM Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3′,5′-monophosphate-selective phosphodiesterase inhibitor. J Pharmacol Exp Ther 1989; 2511000-5
20. Newman S Aerosol deposition considerations in inhalation therapy. Chest 1985; 88152S-60S
21. Fontijin A, Sabadell AJ, Ronco RJ Homogeneous chemiluminescent measurement of nitric oxide with ozone implications for continuous selective monitoring of gaseous air pollutants. Anal Chem 1970; 42575-9
22. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328399-405
23. Weite M, Zwissler B, Habazettl H, Messmer K PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1993; 25329-40
24. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342961-2
25. Broughton BJ, Chaplen P, Knowles P, Lunt E, Pain DL, Wooldridge KRH New inhibitor of reagin-mediated anaphylaxis. Nature 1974; 251650-2
26. Dundore RL, Pratt PF, O'Connor B, Buchholz RA, Pagani ED N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast. Eur J Pharmacol 1991; 20083-7
27. Giaid A, Saleh D Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333214-21
28. Hamet P, Pang S, Tremblay J Atrial natriuretic factor-induced egression of cyclic guanosine 3′5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 1989; 26412364-9
29. Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, Zapol WM Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Ore Res 1993; 72246-54